Presentation to ACIP on recommending higher-dose and adjuvanted seasonal influenza vaccines for adults 65+


Date
Feb 23, 2022

Work presented to the Advisory Committee on Immunization Practices (ACIP) that modeled the potential impact of recommending high-dose, adjuvanted and recombinant vaccines to adults aged 65 and over on seasonal influenza burden in the United States.

Avatar
Sinead E. Morris
Influenza Modeling Consultant

I work at the intersection of mathematical modeling, epidemiology, and infectious diseases.

Related